Mediterranea Medica S. L.   Report issue

Academic/Hospital Phase 3
Founded: Valencia Spain

Organization Overview

First Clinical Trial
2007
NCT00712595
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2010

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

mifepristone (mifeprex) (4 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Endometriosis (Phase 3)

Leiomyoma (Phase 3)

Myofibroma (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 4
  • # of Trial APIs: 1